Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, Ameliorates Nonalcoholic Fatty Liver Disease in Japanese Patients with Type 2 Diabetes Mellitus

Authors
Publication date
20 December 2019
Publisher
東京女子医科大学学会
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Tokyo Women’s Medical University

      redirect
      oaioai:twinkle.repo.nii.ac.jp:000...
      Last time updated on 24/11/2020